CardioVascular and Interventional Radiology

, Volume 36, Issue 3, pp 682–689

Radiofrequency Ablation of Large Renal Angiomyolipoma: Median-Term Follow-Up

Clinical Investigation

Abstract

Purpose

To study the feasibility of percutaneous radiofrequency ablation (RFA) of large angiomyolipomas (AMLs) using saline-cooled electrodes.

Materials and Methods

Institutional Review Board approval for the study was received. Four patients (all female, age range 33–67 years) with large AMLs (maximal axis 6.1–32.4 cm) not suitable for embolotherapy or surgery consented to a trial of RFA. Procedures were performed under computerized tomographic guidance using 14G saline-infused electrodes. Two ablations (diameter 4–7 cm) were undertaken in each patient. Variables studied were technical success, treatment safety, alteration of tumor consistency, tumor size, effect on renal function, and medium-term freedom from haemorrhage.

Results

All four patients underwent successful RFA without any intraprocedural complications. There has been no haemorrhage, or new renal specific symptom, during a minimum 48-month period, and normal renal function has been normal. On follow-up radiological imaging, the tumors have become fattier with involution of the soft-tissue elements (soft tissue–to–total tumor ratio decreased mean [range] of 0.26 [0.14–0.48] to 0.17 [0.04–0.34] U; p = 0.04 [paired Student t test]). Further evidence of treatment effect was the development of a capsule around the ablation zone, but there was no change in overall tumor volume (mean [range] 1,120 [118–2,845] to 1150 [90–3,013] ml; p = 1 [paired Student t test]).

Conclusion

RFA of large AMLs is technically feasible using saline-infused electrodes. The soft-tissue elements decreased in volume; the tumors become fattier; and there has been no renal haemorrhage during a 48-month period.

References

  1. 1.
    Oesterling JE, Fishman EK, Goldman SM, Marshall FF (1986) The management of renal angiomyolipoma. J Urol 135(6):1121–1124PubMedGoogle Scholar
  2. 2.
    Nelson CP, Sanda MP (2002) Contemporary diagnosis and management of renal angiomyolipoma. J Urol 168(4 Pt 1):1315–1325PubMedGoogle Scholar
  3. 3.
    Bissler JJ, Kingswood JC (2004) Renal angiomyolipomata. Kidney Int 66(3):924–934PubMedCrossRefGoogle Scholar
  4. 4.
    Rimon U, Duvdevani M, Garniek A, Golan G, Bensaid P, Ramon J et al (2006) Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol 187(3):762–768PubMedCrossRefGoogle Scholar
  5. 5.
    Ramon J, Rimon U, Garniek A, Golan G, Bensaid P, Kitrey ND et al (2009) Renal angiomyolipoma: Long-term results following selective arterial embolization. Eur Urol 55(5):1155–1161PubMedCrossRefGoogle Scholar
  6. 6.
    Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C et al (2010) Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 105(1):101–106PubMedCrossRefGoogle Scholar
  7. 7.
    Pereira PL, Trübenbach J, Schenk M, Subke J, Kroeber S, Schaefer I et al (2004) Radiofrequency ablation: In vivo comparison of four commercially available devices in pig livers. Radiology 232(2):482–490PubMedCrossRefGoogle Scholar
  8. 8.
    Wienecke R, Fackler I, Linsenmaier U, Mayer K, Licht T, Kretzler M (2006) Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am J Kidney Dis 48(3):e27–e29PubMedCrossRefGoogle Scholar
  9. 9.
    Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM et al (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358(2):140–151PubMedCrossRefGoogle Scholar
  10. 10.
    Chick CM, Tan BS, Cheng C, Taneja M, Lo R, Tan YH et al (2010) Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int 105(3):390–394PubMedCrossRefGoogle Scholar
  11. 11.
    Lee SY, Hsu HH, Chen YC, Huang CC, Wong YC, Wang LJ et al (2009) Embolization of renal angiomyolipomas: short-term and long-term outcomes, complications, and tumor shrinkage. Cardiovasc Intervent Radiol 32(6):1171–1178PubMedCrossRefGoogle Scholar
  12. 12.
    Dickinson M, Ruckle H, Beaghler M, Hadley HR (1998) Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol 49(5):281–286PubMedGoogle Scholar
  13. 13.
    Lenton J, Kessel D, Watkinson AF (2008) Embolization of renal angiomyolipoma: Immediate complications and long-term outcomes. Clin Radiol 63(8):864–870PubMedCrossRefGoogle Scholar
  14. 14.
    Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K (2002) Renal angiomyolipoma: Relationships between tumor size, aneurysm formation, and rupture. Radiology 225(1):78–82PubMedCrossRefGoogle Scholar
  15. 15.
    Han YM, Kim JK, Roh BS, Song HY, Lee JM, Lee YH et al (1997) Renal angiomyolipoma: Selective arterial embolization—Effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology 204(1):65–70PubMedGoogle Scholar
  16. 16.
    Takebayashi S, Horikawa A, Arai M, Iso S, Noguchi K (2009) Transarterial ethanol ablation for sporadic and non-hemorrhaging angiomyolipoma in the kidney. Eur J Radiol 72(1):139–145PubMedCrossRefGoogle Scholar
  17. 17.
    Prevoo W, van den Bosch MA, Horenblas S (2008) Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology 72(1):188–191PubMedCrossRefGoogle Scholar
  18. 18.
    Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ (2003) Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 180(6):1503–1508PubMedCrossRefGoogle Scholar
  19. 19.
    Byrd GF, Lawatsch EJ, Mesrobian HG, Begun F, Langenstroer P (2006) Laparoscopic cryoablation of renal angiomyolipoma. J Urol 176(4 Pt 1):1512–1516PubMedCrossRefGoogle Scholar
  20. 20.
    Johnson SC, Graham S, D’Agostino H, Elmajian DA, Shingleton WB (2009) Percutaneous renal cryoablation of angiomyolipomas in patients with solitary kidneys. Urology 74(6):1246–1249PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2013

Authors and Affiliations

  1. 1.Department of RadiologySt. George’s Hospital and Medical SchoolLondonUK
  2. 2.Department of UrologySt. George’s Hospital and Medical SchoolLondonUK

Personalised recommendations